Home Breaking News GILEAD has set the price of a course of remdesivir 2 –...

GILEAD has set the price of a course of remdesivir 2 – $ 340

0
2


Published the


Pixabay


(AOF) – Gilead has set the price of its remdesivir against the Covid-19 2 $ 340. for a treatment of five days. This experimental drug has not yet been approved by the FDA but has received authorization for emergency use. The price for the insured americans in the private sector is slightly higher : 3 $ 120. The biotech in the us has indicated that this price would be the same for all developed countries. The Institute for Clinical and Economic Review, an organization that evaluates the prices of drugs, was recommended to fix the price of the remdesivir between 2 520 and 2, $ 800.

AOF – MORE INFORMATION

©
FOA

The information AOF reproduced on Capital.fr are extracted from the service information AOF.
This information is protected by intellectual property rights held by OPTION FINANCE SAS, editor of the service of stock information in real-time AOF and its contributors.
Therefore, any reproduction, copy, duplication, modification, transfer, redistribution, translation, commercial use or not, creating a hyperlink, or reuse in any manner whatsoever of such information are subject to the prior written agreement of OPTION FINANCE SAS and of its contributors.
The AOF can be contacted at the following address [email protected]
OPTION FINANCE SAS collects its data from sources it considers to be most safe. However, subject to its gross negligence, OPTION FINANCE SAS and its contributors do not guarantee the absence of errors and defects, even hidden, or completeness, or the lack of conformity to any other use of this data and OPTION FINANCE SAS or one of its contributors, and may not be held liable for any delays or interruptions which could affect access to these.
The user of the service OPTION FINANCE SAS will use the data AOF at its own risk and will have to hold OPTION FINANCE SAS and its contributors harmless from any claim resulting from this use.

Today’s matches live



Source link
https://www.capital.fr/entreprises-marches/gilead-a-fixe-le-prix-dune-cure-de-remdesivir-a-2-340-dollars-1373942

LEAVE A REPLY

Please enter your comment!
Please enter your name here